A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.
Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, antibiotics and other drugs to manage the sometimes debilitating symptoms. However, ...
Therapies to treat IPF are limited ... and cellular interactions in distinct cell populations in chronic obstructive pulmonary disease ...
News Medical on MSN10d
Addressing COPD and metabolic syndrome requires comprehensive research effortsAdditional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
News Medical on MSN13d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPDA study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
In their study, the researchers looked at the effects of cigarette smoke on Mucosal-Associated Invariant T (MAIT) cells, a ...
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback